Clinical Trials Logo

Death, Sudden clinical trials

View clinical trials related to Death, Sudden.

Filter by:

NCT ID: NCT00570869 Completed - Clinical trials for Prevention of Sudden Death

Training Mothers of Infants in Infant Cardiopulmonary Resuscitation (CPR)

Start date: January 2008
Phase: N/A
Study type: Interventional

This research will be a prospective, cohort study to determine if mothers of infants/newborns are more willing to complete CPR training using a 22-minute instructional DVD and infant manikin versus traditional four hour didactic instruction. Study Hypothesis: A 22-minute instructional DVD and infant manikin will be an effective and preferred tool for teaching mothers of infants infant CPR. Objectives 1. To determine if mothers of infants are more likely to complete infant CPR training with a 22-minute instructional DVD and infant manikin, than by attending a traditional CPR class. 2. To determine if learning infant CPR with a 22-minute instructional DVD and infant manikin is as effective as attending traditional infant CPR class. 3. To examine the number of mothers that were offered the opportunity to learn infant CPR either as part of their prenatal classes, or upon the birth of their infant. 4. To examine the number of mothers who have been previously trained in CPR. 5. To examine the reasons that mothers have been previously trained in CPR (e.g., mandated by work/career vs. personal reasons). 6. To examine the multiplier effect of an at home CPR education using a 22-minute instructional DVD and infant manikin at the time of the follow up phone call.

NCT ID: NCT00510731 Withdrawn - Clinical trials for Tachycardia, Ventricular

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

VITAL
Start date: November 2006
Phase: N/A
Study type: Observational

This is a prospective study to evaluating the ability of the PD2i Cardiac Analyzer to predict the risk of serious heart rhythm abnormalities in high-risk patients that do not already have an Implantable Cardioverter Defibrillator.

NCT ID: NCT00478933 Completed - Atrial Fibrillation Clinical Trials

DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.

DISCOVERY
Start date: February 2007
Phase: N/A
Study type: Interventional

To prospectively evaluate if the analysis of genetic polymorphisms can be used to identify patients at risk of ventricular tachycardia. To evaluate the influence of ICD-based diagnostic information on the long term treatment and management of primary prevention ICD-patients.

NCT ID: NCT00469794 Recruiting - Sudden Death Clinical Trials

The Significance of Arrhythmias in Athletes

Athlete
Start date: May 2006
Phase: N/A
Study type: Observational

Athletes with complex ventricular arrhythmias are potentially at risk of sudden death. The aim of the study is to investigate the relevance of ventricular tachyarrhythmias induced by an exercise test in a retrospectively evaluated athletic population.

NCT ID: NCT00439790 Completed - Heart Failure Clinical Trials

Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients

Start date: January 2007
Phase: N/A
Study type: Observational

The aim of this study is to analyze whether the sympathetic tone, measured indirectly and directly by muscle sympathetic nerve activity recording, is elevated in patients with heart failure receiving an appropriate shock from their implantable cardiac defibrillator (ICD) compared to heart failure patients not receiving a shock from their ICD. All parameters measured in this study will be used to build a risk algorithm able to identify heart failure patients at high risk for sudden cardiac death who could receive an ICD.

NCT ID: NCT00399503 Completed - Clinical trials for Myocardial Infarction

Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack

Start date: September 2001
Phase: N/A
Study type: Observational

This study evaluates the usefulness of noninvasive tests of the structure of the heart and the nervous system controlling the heart. It will assess whether combining tests that evaluate heart structure with others that measure the nervous system controlling the heart will identify most patients who develop serious heart rhythm problems after a heart attack.

NCT ID: NCT00382928 Completed - Clinical trials for Ventricular Fibrillation

Automatic External Defibrillation Monitoring in Cardiac Arrest

Start date: October 2006
Phase: Phase 1
Study type: Interventional

We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted to the telemetry ward, all other treatments being constant including cardiopulmonary resuscitation. We hypothesize that the automatic, rapid, accurate and specific diagnostic and therapeutic technology used in AECDs will further increase the rate of survival in patients with cardiac arrest through rapid and automatic defibrillation, independent of operator initiation, as compared to standard cardiopulmonary resuscitation initiated by healthcare providers.

NCT ID: NCT00376532 Completed - Arrythmia Clinical Trials

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

EMMA
Start date: September 2006
Phase: N/A
Study type: Observational

Assess whether serum levels of MMP 2 and or MMP 9 correlate with episodes of ventricular tachycardia or fibrillation in patients who have implantable cardioverter defibrillator devices.

NCT ID: NCT00241800 Completed - Clinical trials for Cardiovascular Diseases

Medications and the Risk of Sudden Cardiac Death

Start date: September 2005
Phase: N/A
Study type: Observational

To investigate a potential relationship between four different classes of non-cardiovascular drugs and the risk of sudden cardiac death.

NCT ID: NCT00203333 Completed - Arrhythmia Clinical Trials

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Start date: April 2002
Phase: Phase 2/Phase 3
Study type: Observational

People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.